Ad is loading...
AZNCF
Price
$134.86
Change
+$1.34 (+1.00%)
Updated
Dec 6 closing price
NVS
Price
$101.98
Change
-$0.54 (-0.53%)
Updated
Dec 6, 04:59 PM (EDT)
54 days until earnings call
Ad is loading...

AZNCF vs NVS

Header iconAZNCF vs NVS Comparison
Open Charts AZNCF vs NVSBanner chart's image
AstraZeneca
Price$134.86
Change+$1.34 (+1.00%)
Volume$3.44K
CapitalizationN/A
Novartis AG
Price$101.98
Change-$0.54 (-0.53%)
Volume$5K
CapitalizationN/A
AZNCF vs NVS Comparison Chart
Loading...
AZNCF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AZNCF vs. NVS commentary
Dec 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZNCF is a Hold and NVS is a Buy.

COMPARISON
Comparison
Dec 09, 2024
Stock price -- (AZNCF: $134.86 vs. NVS: $101.99)
Brand notoriety: AZNCF and NVS are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZNCF: 224% vs. NVS: 70%
Market capitalization -- AZNCF: $222.83B vs. NVS: $197.93B
AZNCF [@Pharmaceuticals: Major] is valued at $222.83B. NVS’s [@Pharmaceuticals: Major] market capitalization is $197.93B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZNCF’s FA Score shows that 1 FA rating(s) are green whileNVS’s FA Score has 3 green FA rating(s).

  • AZNCF’s FA Score: 1 green, 4 red.
  • NVS’s FA Score: 3 green, 2 red.
According to our system of comparison, NVS is a better buy in the long-term than AZNCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZNCF’s TA Score shows that 4 TA indicator(s) are bullish while NVS’s TA Score has 5 bullish TA indicator(s).

  • AZNCF’s TA Score: 4 bullish, 5 bearish.
  • NVS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NVS is a better buy in the short-term than AZNCF.

Price Growth

AZNCF (@Pharmaceuticals: Major) experienced а -1.20% price change this week, while NVS (@Pharmaceuticals: Major) price change was -3.57% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.17%. For the same industry, the average monthly price growth was -6.26%, and the average quarterly price growth was -0.12%.

Reported Earning Dates

NVS is expected to report earnings on Jan 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.17% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZNCF($223B) has a higher market cap than NVS($198B). AZNCF has higher P/E ratio than NVS: AZNCF (36.10) vs NVS (23.38). NVS YTD gains are higher at: 4.870 vs. AZNCF (0.305). NVS has higher annual earnings (EBITDA): 18.3B vs. AZNCF (12.9B). NVS has more cash in the bank: 14B vs. AZNCF (5.81B). NVS has less debt than AZNCF: NVS (26.3B) vs AZNCF (29.8B). NVS (46.7B) and AZNCF (44.5B) have equivalent revenues.
AZNCFNVSAZNCF / NVS
Capitalization223B198B113%
EBITDA12.9B18.3B70%
Gain YTD0.3054.8706%
P/E Ratio36.1023.38154%
Revenue44.5B46.7B95%
Total Cash5.81B14B42%
Total Debt29.8B26.3B113%
FUNDAMENTALS RATINGS
AZNCF vs NVS: Fundamental Ratings
AZNCF
NVS
OUTLOOK RATING
1..100
506
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
4319
SMR RATING
1..100
5222
PRICE GROWTH RATING
1..100
6060
P/E GROWTH RATING
1..100
7590
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVS's Valuation (12) in the Pharmaceuticals Major industry is in the same range as AZNCF (21) in the null industry. This means that NVS’s stock grew similarly to AZNCF’s over the last 12 months.

NVS's Profit vs Risk Rating (19) in the Pharmaceuticals Major industry is in the same range as AZNCF (43) in the null industry. This means that NVS’s stock grew similarly to AZNCF’s over the last 12 months.

NVS's SMR Rating (22) in the Pharmaceuticals Major industry is in the same range as AZNCF (52) in the null industry. This means that NVS’s stock grew similarly to AZNCF’s over the last 12 months.

NVS's Price Growth Rating (60) in the Pharmaceuticals Major industry is in the same range as AZNCF (60) in the null industry. This means that NVS’s stock grew similarly to AZNCF’s over the last 12 months.

AZNCF's P/E Growth Rating (75) in the null industry is in the same range as NVS (90) in the Pharmaceuticals Major industry. This means that AZNCF’s stock grew similarly to NVS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNCFNVS
RSI
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
52%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
59%
Bullish Trend 3 days ago
38%
Momentum
ODDS (%)
Bullish Trend 3 days ago
59%
Bearish Trend 3 days ago
47%
MACD
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
50%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
43%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
38%
Advances
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 10 days ago
46%
Declines
ODDS (%)
Bearish Trend 5 days ago
50%
Bearish Trend 5 days ago
44%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
58%
Bullish Trend 3 days ago
56%
Aroon
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
29%
View a ticker or compare two or three
Ad is loading...
AZNCF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MAGG20.570.04
+0.19%
Madison Aggregate Bond ETF
ARGT84.070.15
+0.18%
Global X MSCI Argentina ETF
IAGG52.450.04
+0.08%
iShares Core International Aggt Bd ETF
HLGE32.99N/A
N/A
Hartford Longevity Economy ETF
SRET20.90-0.05
-0.24%
Global X SuperDividend® REIT ETF

AZNCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZNCF has been loosely correlated with AZN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AZNCF jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZNCF
1D Price
Change %
AZNCF100%
+1.00%
AZN - AZNCF
48%
Loosely correlated
+0.99%
NVS - AZNCF
24%
Poorly correlated
-0.52%
SNY - AZNCF
23%
Poorly correlated
-0.10%
MRK - AZNCF
19%
Poorly correlated
-0.44%
BAYRY - AZNCF
18%
Poorly correlated
+2.75%
More

NVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been loosely correlated with AZN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NVS jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
-0.52%
AZN - NVS
50%
Loosely correlated
+0.99%
SNY - NVS
40%
Loosely correlated
-0.10%
GSK - NVS
39%
Loosely correlated
+0.12%
RHHBY - NVS
37%
Loosely correlated
+0.55%
JNJ - NVS
34%
Loosely correlated
-0.14%
More